Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Surface Oncology revenue
Surface Oncology's revenue is $30.0 million.
What is Surface Oncology's revenue?
- Surface Oncology's revenue growth from 2017 to 2022 is 133.9%.
- Surface Oncology has 51 employees, and the revenue per employee ratio is $588,235.
- Surface Oncology's peak quarterly revenue was $87.6M in 2020(q4).
- Surface Oncology peak revenue was $126.2M in 2020.
- Surface Oncology annual revenue for 2021 was 2.7M, -97.87% growth from 2020.
- Surface Oncology annual revenue for 2022 was 30.0M, 1,016.49% growth from 2021.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Surface Oncology historical revenue
Surface Oncology's peak revenue was $126.2M in 2020. The peak quarterly revenue was $87.6M in 2020(q4).
Surface Oncology's revenue increased from $12.8m in 2017 to $30.0M currently. That's a 133.9% change in annual revenue.
Surface Oncology annual revenue
Surface Oncology annual revenue over time
| Fiscal year / year | Surface Oncology revenue |
|---|---|
| 2017 | $12.8M |
| 2018 | $59.4M |
| 2019 | $15.4M |
| 2020 | $126.2M |
| 2021 | $2.7M |
| 2022 | $30.0M |
How accurately did Surface Oncology's revenue projections match actual performance?
Surface Oncology annual growth
Surface Oncology saw the greatest revenue growth in 2022, when revenue increased by 1,016.49%.
Surface Oncology had the lowest revenue growth in 2021, when revenue changed by -97.87%.
Surface Oncology annual growth rate over time
| Year | Surface Oncology growth |
|---|---|
| 2018 | 363%↑ |
| 2019 | -74%↓ |
| 2020 | 721%↑ |
| 2021 | -98%↓ |
| 2022 | 1016%↑ |
Surface Oncology quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Surface Oncology quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2017 | - | - | - | $2.5M |
| 2018 | $45.5M | $2.4M | $1.7M | $9.8M |
| 2019 | $14.4M | $143,000 | $344,000 | $439,000 |
| 2020 | $38.6M | - | - | $87.6M |
| 2021 | $1.6M | $515,000 | $392,000 | $155,000 |
| 2022 | $30.0M | - | - | - |
Surface Oncology jobs nearby
Do you work at Surface Oncology?
Did Surface Oncology meet its revenue projections?
Surface Oncology financing
Surface Oncology received early financing of $35.0M on 2015-01-08.
| Series | Round size | Date |
|---|---|---|
| Series A | $35M | 01/2015 |
| Post Ipo Equity | $28.9M | 05/2020 |
Surface Oncology investors
| Investors | Security type |
|---|---|
| Novartis Institutes for BioMedical Research Inc | Series A |
| New Enterprise Associates | Series A |
| Lilly Ventures | Series A |
| F-Prime Capital | Series A |
| Amgen Inc. | Series A |
| Atlas Venture | Series A |
| Elliott Sigal | Series A |
| EcoR1 Capital, LLC | Post Ipo Equity |
| RS Investments | Post Ipo Equity |
| Biotechnology Value Fund | Post Ipo Equity |
| Venrock Healthcare Capital Partners | Post Ipo Equity |
Surface Oncology competitors
Surface Oncology's top competitor, Mersana Therapeutics, earned an annual revenue of $40.5M.
Surface Oncology's smallest competitor is Trillium Therapeutics with revenue of $148.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Bolt Biotherapeutics | - | $7.7M | 91 | - |
| Trillium Therapeutics | - | $148,000 | 20 | - |
| Mersana Therapeutics | - | $40.5M | 169 | - |
| Immune-Onc Therapeutics | - | $440,000 | 17 | - |
| AbVitro | - | $10.0M | 350 | - |
| Pionyr Immunotherapeutics | - | $1.6M | 58 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Surface Oncology highest paying jobs
Zippia gives an in-depth look into the details of Surface Oncology, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Surface Oncology. The employee data is based on information from people who have self-reported their past or current employments at Surface Oncology. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Surface Oncology. The data presented on this page does not represent the view of Surface Oncology and its employees or that of Zippia.
Surface Oncology may also be known as or be related to SURFACE ONCOLOGY, INC., Surface Oncology, Surface Oncology Inc, Surface Oncology Inc. and Surface Oncology, Inc.